Search research articles
Contact Us
Filters
Showing results (31-40 of 81) with videos related to
Page
of 9
Sort By:
Cell Reports
|
April 12, 2018
Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes
Alexander Solovyov, Nicolas Vabret, Kshitij S Arora, et al.
Mbio
|
April 9, 2015
Intrahost dynamics of antiviral resistance in influenza A virus reflect complex patterns of segment linkage, reassortment, and natural selection
Matthew B Rogers, Timothy Song, Robert Sebra, et al.
Pigment Cell & Melanoma Research
|
February 26, 2020
Genomic analysis of metastatic melanoma in an adult with giant congenital melanocytic nevus
Li-Wei Chang, Ramiz Iqbal, Brateil Badal, et al.
Pigment Cell & Melanoma Research
|
April 18, 2018
FBXW7 regulates a mitochondrial transcription program by modulating MITF
Franco Abbate, Brateil Badal, Karen Mendelson, et al.
Leukemia
|
December 15, 2019
Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma
Francesco Maura, Even H Rustad, Venkata Yellapantula, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 18, 2015
Distinguishing the immunostimulatory properties of noncoding RNAs expressed in cancer cells
Antoine Tanne, Luciana R Muniz, Anna Puzio-Kuter, et al.
Nature
|
November 14, 2017
A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
Marta Łuksza, Nadeem Riaz, Vladimir Makarov, et al.
Nature Communications
|
July 20, 2023
Identification of transcriptional programs using dense vector representations defined by mutual information with GeneVector
Nicholas Ceglia, Zachary Sethna, Samuel S Freeman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 30, 2026
YIA26-003: Characterizing the Peripheral T-Cell Repertoire in Patients With Unresectable Melanoma Treated With the IDO- and PD-L1 Targeted Peptide Vaccine IO102-IO103 and Nivolumab-Relatlimab Fixed-Dose Combination
James W Smithy, Victoria Ciallella, Claire Thant, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 29, 2026
YIA26-003: Characterizing the Peripheral T-Cell Repertoire in Patients With Unresectable Melanoma Treated With the IDO- and PD-L1 Targeted Peptide Vaccine IO102-IO103 and Nivolumab-Relatlimab Fixed-Dose Combination
James W Smithy, Victoria Ciallella, Claire Thant, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 81) with videos related to
Sort By:
Page
of 9
Cell Reports
|
April 12, 2018
Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes
Alexander Solovyov, Nicolas Vabret, Kshitij S Arora, et al.
Mbio
|
April 9, 2015
Intrahost dynamics of antiviral resistance in influenza A virus reflect complex patterns of segment linkage, reassortment, and natural selection
Matthew B Rogers, Timothy Song, Robert Sebra, et al.
Pigment Cell & Melanoma Research
|
February 26, 2020
Genomic analysis of metastatic melanoma in an adult with giant congenital melanocytic nevus
Li-Wei Chang, Ramiz Iqbal, Brateil Badal, et al.
Pigment Cell & Melanoma Research
|
April 18, 2018
FBXW7 regulates a mitochondrial transcription program by modulating MITF
Franco Abbate, Brateil Badal, Karen Mendelson, et al.
Leukemia
|
December 15, 2019
Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma
Francesco Maura, Even H Rustad, Venkata Yellapantula, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 18, 2015
Distinguishing the immunostimulatory properties of noncoding RNAs expressed in cancer cells
Antoine Tanne, Luciana R Muniz, Anna Puzio-Kuter, et al.
Nature
|
November 14, 2017
A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
Marta Łuksza, Nadeem Riaz, Vladimir Makarov, et al.
Nature Communications
|
July 20, 2023
Identification of transcriptional programs using dense vector representations defined by mutual information with GeneVector
Nicholas Ceglia, Zachary Sethna, Samuel S Freeman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 30, 2026
YIA26-003: Characterizing the Peripheral T-Cell Repertoire in Patients With Unresectable Melanoma Treated With the IDO- and PD-L1 Targeted Peptide Vaccine IO102-IO103 and Nivolumab-Relatlimab Fixed-Dose Combination
James W Smithy, Victoria Ciallella, Claire Thant, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 29, 2026
YIA26-003: Characterizing the Peripheral T-Cell Repertoire in Patients With Unresectable Melanoma Treated With the IDO- and PD-L1 Targeted Peptide Vaccine IO102-IO103 and Nivolumab-Relatlimab Fixed-Dose Combination
James W Smithy, Victoria Ciallella, Claire Thant, et al.
Page
of 9